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ABSTRACT
Aim A modified Delphi approach was used to develop 
consensus opinion among British Society for Cardiac 
Imaging/British Society of Cardiac CT (BSCI/BSCCT) 
members in order to prioritise research questions in 
cardiovascular imaging.
Methods All members of the BSCI/BSCCT were invited to 
submit research questions that they considered to be of 
the highest clinical and/or academic priority in the field of 
cardiovascular imaging (phase 1). Subsequently a steering 
committee removed duplicate questions and combined 
questions of a similar theme by consensus agreement 
where appropriate. BSCI/BSCCT members were invited 
to rank the resulting research questions in two further 
iterative rounds (phases 2 and 3) to determine a final list 
of high- priority research questions.
Results A total of 111 research questions were submitted 
in phase 1 by 30 BSCI/BSCCT members. While there was 
a broad range of topics, from determining the optimal 
features/markers of the vulnerable plaque to investigating 
how cardiac imaging can best be used to maximise clinical 
outcomes and economic costs, multimodality imaging- 
related (n=44, 40%) questions dominated the categories 
and coronary artery imaging (n=40, 36%) was the most 
common topic. Over two iterative rounds of prioritisation of 
these research questions, the original 111 were reduced to 
75 questions in round 2, and 25 in round 3. From these 25 
a final Top 10 list was distilled by consensus grouping.
Conclusion This study has identified and ranked the top 
research priorities in cardiovascular imaging, as identified 
by the BSCI/BSCCT membership. This is a first step 
towards identifying the cardiovascular imaging research 
priorities within the UK and may assist researchers and 
funding bodies alike in setting priorities.
INTRODUCTION
Cardiovascular imaging (CI) has significantly 
enhanced the diagnosis of all forms of heart 
disease and is now often centre stage to the 
patient care pathway. Following rapid techno-
logical advancement the cardiovascular (CV) 
physician has access to a wide armamentarium 
of invasive and non- invasive imaging modali-
ties, including invasive coronary angiography, 
echocardiography, CT, nuclear imaging and 
MRI.1 In the UK alone over 500 000 non- 
invasive cardiac imaging examinations are 
performed every year, with an annual growth 
rate of 3%.2 This is due to a growing body 
of evidence supporting its use as outlined in 
multiple national appropriateness and guide-
line documents covering a wide spectrum of 
heart diseases.3 Additionally, many research 
studies testing novel CV medicines and inter-
ventional therapies now use CI as either 
primary or secondary outcomes, or as surro-
gate markers. However, consensus opinion 
on the major research priorities for CI in the 
UK is currently unknown.
British CV research, and specifically 
cardiovascular imaging research (CIR) is 
world leading, yet is facing multiple chal-
lenges not least the potential loss of access 
to significant funding sources from Euro-
pean research funding bodies such as the 
Horizon programme. It is in this context 
that the British Heart Foundation (BHF) 
has engaged with multiple stakeholders 
including the British Cardiovascular Society 
(BCS) with all its affiliated Societies (of which 
the British Society for Cardiac Imaging/
British Society of Cardiac CT (BSCI/BSCCT) 
is one member) and established the BHF- 
Clinical Research Collaborative (CRC). The 
Key questions
What is already known about this subject?
 ► Cardiovascular imaging has revolutionised the di-
agnosis and treatment of heart disease. Research 
resources should be deployed in areas likely to have 
the greatest clinical impact. A modified Delphi pro-
cess can be used to develop a list of priorities by 
consensus from a group of experts.
What does this study add?
 ► Our survey aims to develop a list of high- priority 
clinical research questions in cardiovascular imag-
ing using a modified Delphi approach to help focus 
future research.
How might this impact on clinical practice?
 ► This list of 10 high- priority research questions in 
cardiovascular imaging will facilitate funding ap-
plications and design high- quality collaborative re-
search over the coming years.
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BHF- CRC aims to act as a catalyst for CV research collab-
orations by providing enabling infrastructure, simplifying 
and democratising CV research. It was in the context of 
the founding meeting of the BHF- CRC that the research 
subcommittee of the BSCI/BSCCT decided to formulate 
its own research priorities.
A modified Delphi process can be used to develop a 
list of priorities by consensus from a group of experts, 
specifically its own membership. This method has been 
extensively used by a number of surgical specialties4–7 to 
develop research priorities and importantly is also the 
method used to formulate the Royal College of Radiology 
iREFER guidelines.8 To date there has been no compre-
hensive undertaking to determine research priorities in 
the subspecialty of CI. Such information will be invalu-
able to centres involved in CIR and funding bodies alike. 
Specifically, if taken up by other BHF- CRC- affiliated and/
or BCS- affiliated groups it could be the first step towards 
creating a comprehensive picture of CV research prior-
ities. In addition, this information will facilitate multi-
centre collaboration on important research topics.
This study, organised by the BSCI/BSCCT, aims to 
develop a Top 10 list of clinically focused CV research 
questions that are thought to have immediate transla-
tional potential to advance CV care.
METHODS
A three- phase modified Delphi process was undertaken 
(figure 1) using established methodology, as previously 
described.4–7 9 10 This included the submission of research 
questions by members of the BSCI/BSCCT followed by 
two distinct rounds of prioritisation and question ranking.
Phase 1
A steering committee (GLY, JWM, MCW, MW, MS) was 
formed from the research subcommittee of the BSCI/
BSCCT executive committee. The steering committee 
was composed of cardiologists, radiologists and a lay 
representative with previous experience of the modified 
Delphi process.
All BSCI/BSCCT members were invited by email to 
submit research questions relating to CI via an online 
survey form (http:// surveymonkey. co. uk). There was 
no limit on the number of research questions that an 
individual could submit. The survey remained open for 
2 months with two reminder emails sent to the BSCI/
BSCCT membership during this period.
Submitted questions were collated and classified by 
the steering committee based on modality and area of 
research. Modality classification was divided into the 
following subcategories: (1) CT, (2) MRI, (3) nuclear 
medicine, and (4) multimodality. Area of research clas-
sification included the following subcategories: (1) coro-
nary, (2) myocardium, (3) structural, (4) valvular, (5) 
cardio- oncology, (6) vascular, (7) congenital, (8) harm/
side effects, (9) outcomes, (10) research technique, (11) 
technological advancement, (12) economic impact, 
(13) artificial intelligence, and (14) other/general. Any 
disagreements regarding categorisation were resolved by 
consensus.
Duplicate questions were removed. Similar questions 
were combined following discussion by the steering 
group into a single question. Care was taken not to alter 
the meaning of the original questions when questions 
were combined or rephrased.
Phase 2
BSCI/BSCCT members were invited by email to priori-
tise the CIR questions identified during phase 1. Using 
an online survey form (http:// surveymonkey. co. uk) 
research questions were presented in a random order 
for each respondent . Respondents were asked to score 
each question based on their own perception of the clin-
ical importance using a 5- point Likert scale (1—lowest 
priority to 5—highest priority). The survey remained 
open for 2 months with two email reminders sent to all 
BSCI/BSCCT members.
The results of the round 2 prioritisation were reviewed 
by the steering committee and a ‘cut- off’ point agreed 
by consensus in order to identify the highest scoring 25 
questions.
Phase 3
BSCI/BSCCT members were invited by email to perform 
a final round of prioritisation on the 25 questions iden-
tified in phase 2 using an online survey form (http:// 
surveymonkey. co. uk). Research questions were provided 
Figure 1 Modified Delphi process for cardiovascular 
imaging research prioritisation.
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in a random order for each respondent. Using the same 
5- point Likert scale respondents were asked to score 
each question on the perceived clinical importance. The 
survey remained open for 2 months with two reminder 
emails sent to all BSCI/BSCCT remembers. Results were 
reviewed by the steering committee to identify the final 
list of prioritised questions.
Statistical analysis
Weighted average scores were generated by Survey-
Monkey for each question when each phase of the survey 
was closed. These weights were downloaded from the 
SurveyMonkey website in a Microsoft Excel spreadsheet 
format. The weighted averages were used to prioritise 
the research questions during each of the phases of the 
survey, with questions with the highest weighted average 
having the highest priority.
RESULTS
One hundred and eleven research questions were 
submitted by 30 BSCI/BSCCT members in phase 1, 
representing participation of ~7% of the BSCI/BSCCT 
membership. Research questions regarding multimo-
dality imaging were the most frequent (n=44, 40%), 
followed by those regarding CT (n=33, 30%, figure 2). 
The most frequent research topic in the submitted ques-
tions was coronary artery disease (n=40, 36%, figure 3).
The submitted questions were reviewed by the steering 
committee and duplicate or similar questions were 
combined or amended, leaving 75 questions available 
for prioritisation in phase 2. Thirty- eight BSCI/BSCCT 
members (9%) participated in the phase 2 research ques-
tion prioritisation. The mean weighted average ques-
tion score was 3.19, with a range from 2.56 to 3.84. The 
complete question list in the order of priority is shown in 
online supplemental appendix 1.
A cut- off value for the weighted average was set as 3.31 in 
order to identify the top 25 research questions for prior-
itisation in phase 3. Forty BSCI/BSCCT members (10%) 
participated in phase 3 research question prioritisation. 
The mean weighted average question score was 3.54, with 
a range from 3.13 to 3.93. The top 25 research questions 
ordered by priority are shown in table 1.
A cut- off value for the weighted average was set as 3.60 
in order to identify the final top 10 research questions in 
CI . Of these 10 questions, 6 (60%) related to stable coro-
nary artery disease, 2 (20%) to acute coronary syndrome, 
1 (10%) to arrhythmias and 1 (10%) to a wider question 
on the incorporation of multimodality imaging into clin-
ical practice (table 2).
DISCUSSION
This study has produced and ranked high- priority 
research questions related to non- invasive CVI as defined 
by the BSCI/BSCCT expert membership. To our knowl-
edge, this is the first time that such a project has been 
undertaken in the field of CI. It is hoped and anticipated 
that this undertaking will stimulate CV research collab-
oration within (but also beyond) the BSCI/BSCCT and 
inform researchers and research funding bodies alike.
The top 10 priority list has a strong emphasis on coro-
nary artery disease (priorities 1, 2, 5, 6, 7, 8, 10). This 
was a consistent theme from the submitted questions in 
phase 1 through to the final prioritisation. This is unsur-
prising as the investigation of stable coronary artery 
disease and its acute presentation represents a significant 
clinical workload for both cardiologists and radiologists 
involved in CI in the UK.11 The Top 10 list also includes 
questions regarding optimising of imaging protocols, 
choice of imaging strategies, improving patient outcomes 
and assessing economic impact (priorities 2, 5, 6, 8, 10).
It needs to be emphasised that participants were asked 
to rank questions in order of their clinical priority. The 
study therefore concentrated on translational research 
spectrum as opposed to the preclinical/bench spectrum. 
Figure 2 Imaging modalities referred to the submitted 
research questions.
Figure 3 The range of topics referred to the submitted 
research questions. AI, artificial intelligence.
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This is relevant and justified in so far as the BSCI/BSCCT 
membership is mainly composed of clinically active prac-
titioners and several other BCS- affiliated groups exist 
(British Society for Cardiovascular Research, British 
Atherosclerosis Society, Society for Cardiological Science 
and Technology, to name just a few) dedicated to preclin-
ical and/or bench side science.
Indeed, the BSCI/BSCCT membership is a diverse 
group of clinically focused radiologists and cardiologists 
from throughout the UK and Ireland. The BSCI/BSCCT 
is the specialist interest group for CI of the Royal College 
of Radiologists and is also a member of the Imaging 
Council of the BCS. Although the membership does 
include many practitioners who use multiple modalities 
it has a particular focus on CT as there are other UK 
imaging societies specifically dedicated to CV MRI and 
cardiac nuclear imaging—that is, the British Society of 
Cardiovascular Magnetic Resonance and British Nuclear 
Cardiology Society, respectively. Therefore, by definition 
this exercise has produced a focused and unquestion-
ably biased result which was inherent to the study design. 
As mentioned above it is hoped this study is the first 
piece of the wider puzzle. Furthermore, in addition to 
other affiliated groups and clinical stakeholders, future 
efforts should include members of the public given the 
increasing emphasis on patient and public involvement to 
determine where future CV research should be focused.12
A further limitation of the study is that only approx-
imately 10%–15% of the BSCI/BSCCT membership 
participated in the various iterations of the study. 
Similar studies using the modified Delphi methodology 
have demonstrated a similar response rate.6 Therefore, 
although low, this is probably a fair reflection of the 
engagement such an exercise can deliver. Lastly, this 
study was conducted in the pre- COVID-19 era and it is 
acknowledged that research prioritise since they have 
significantly shifted to address the not inconsiderable 
acute and long- term CV aspects of this global pandemic.
This study has identified and ranked the top research 
priorities in the field of CI as defined by the BSCI/BSCCT 
membership in the pre- COVID-19 era. The emerging 
theme has a strong emphasis on coronary artery disease 
Table 1 Top 25 BSCI/BSCCT research priorities in descending order
Priority Research question
1 Is there a combination of stenosis/CTFFR/plaque features that identify a situation where the benefit of a stent outweighs its risks?
2 How can we best target cardiac imaging to optimise its yield in terms of outcomes and economic costs?
3 Is there a mortality/morbidity reduction through the wider use of CTCA?
4 What is the optimum imaging/investigative strategy in acute coronary syndromes?
5 What are the outcomes of CTCA use in low- risk ACS patients?
6 How can we limit increases in downstream costs and healthcare utilisation after CTCA?
7 What are the optimal features/markers of the vulnerable plaque?
8 What is the role of CTFFR in clinical practice?
9 Can we identify and characterise biomarkers of sudden cardiac death/arrhythmias in order to develop better risk stratification tools?
10 What is the economic impact of CTFFR in routine practice?
11 Can we standardise advanced MRI techniques (eg, late gadolinium enhancement quantification, mapping)?
12 How do different cardiac imaging strategies affect downstream testing?
13 How useful are TAVI (Transcatheter Aortic Valve Implantation) CTs in management decisions when many people who are worked up don't 
end up getting TAVI, is there a more cost- effective strategy to predict who needs TAVI CT?
14 Can cardiovascular imaging be used to predict/improve outcomes in cardiomyopathy imaging?
15 How can we reduce the impact of calcification on CTCA diagnostic accuracy, in a radiation and time- efficient manner?
16 Can we use artificial intelligence to enable decision support tools for the use of cardiovascular imaging?
17 What is the optimum follow- up interval for imaging of cardiovascular disease (eg, aneurysms, dissection)?
18 Can CTCA replace functional imaging for stable angina?
19 Can we develop methods to improve accuracy in CTCA assessment of in- stent disease?
20 What is the role of artificial intelligence in cardiovascular disease?
21 Is there a role for early use of cardiac CT in confirmed/high- risk ACS?
22 What are the barriers to the implementation of evidence- based imaging strategies in cardiovascular imaging?
23 Which patients do not need or derive no benefit from cardiovascular imaging?
24 Do any advanced imaging modalities improve outcome in dilated cardiomyopathy?
25 Has the change of the NICE guidance resulted in more inappropriate CTCA referrals?
BSCI/BSCCT, British Society for Cardiac Imaging/British Society of Cardiac CT; NICE, National Institute for Health and Care Excellence.
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research and identification of the vulnerable patient (and 
plaque). It is hoped that this although biased (through 
the lens of the BSCI/BSCCT membership) piece of work 
will stimulate sister societies and other BHF- CRC and 
BCS- affiliated groups to undertake similar if not identical 
exercises so that the funding researchers, funding and 
government bodies gain a comprehensive picture of the 
UK CV research priorities and needs.
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